Cooley

Christophe Beauduin

Deals
3
Latest
Apr 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 3 deals
Deals by year
Christophe Beauduin: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Christophe Beauduin was named on, most recent first
Apr 2026 CrossBridge Bio –Eli Lilly and CompanyAcquisitionLegal adviser to CrossBridge Bio (target)Announced300.0Biotech+2Eli Lilly and Company acquisition of CrossBridge Bio
Feb 2026 35Pharma –GSKAcquisitionLegal adviser to 35Pharma (target)Announced950.0Biotech+1GSK acquisition of 35Pharma
Jan 2026 Repare Therapeutics –XenoTherapeuticsAcquisitionLegal adviser to Repare Therapeutics (target)Completed–Biotech+1XenoTherapeutics acquisition of Repare Therapeutics

Deals where Christophe Beauduin is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.